The first issue of the second volume of MIDRU newsletters sees some changes: more pages, more information useful directly to researchers, and more detail about the studies and trials going on here at HEFT. Focused primarily on research of all kinds, the newsletter is the best way to keep up to date with the latest studies, funding and governance issues, and more. Contact us to be put on our distribution list for the print copy, or check back here regularly to download the latest issue in PDF format!
|Download Issue 2.1
Message from Professor Milligan, clinical trials in retinopathy and critical care, BALTI-2 in the Lancet, funding opportunities, patient and public involvement, training opportunities and more.
Back issues from Volume I are available here.